Showing 1 - 5 results of 5 for search 'Shunji Kozaki', query time: 0.03s Refine Results
  1. 1
    Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins

    Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins by Toshiaki Takeuchi, Tsuyoshi Okuno, Ai Miyashiro, Tomoko Kohda, Ryosuke Miyamoto, Yuishin Izumi, Shunji Kozaki, Ryuji Kaji

    Published 2021-11-01
    Get full text
    Article
  2. 2
    A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA

    A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA by Ryuji Kaji, Ai Miyashiro, Nori Sato, Taiki Furumoto, Toshiaki Takeuchi, Ryosuke Miyamoto, Tomoko Kohda, Yuishin Izumi, Shunji Kozaki

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010.

    Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010. by Piyada Wangroongsarb, Tomoko Kohda, Chutima Jittaprasartsin, Karun Suthivarakom, Thanitchi Kamthalang, Kaoru Umeda, Pathom Sawanpanyalert, Shunji Kozaki, Kazuyoshi Ikuta

    Published 2014-01-01
    Get full text
    Article
  4. 4
    Inhibition of Membrane Na+ Channels by A Type Botulinum Toxin at Femtomolar Concentrations in Central and Peripheral Neurons

    Inhibition of Membrane Na+ Channels by A Type Botulinum Toxin at Femtomolar Concentrations in Central and Peripheral Neurons by Min-Chul Shin, Masahito Wakita, Du-Jie Xie, Toshitaka Yamaga, Satomi Iwata, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Shunji Kozaki, Norio Akaike

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Type A1 but Not Type A2 Botulinum Toxin Decreases the Grip Strength of the Contralateral Foreleg Through Axonal Transport From the Toxin-Treated Foreleg of Rats

    Type A1 but Not Type A2 Botulinum Toxin Decreases the Grip Strength of the Contralateral Foreleg Through Axonal Transport From the Toxin-Treated Foreleg of Rats by Yasushi Torii, Norio Akaike, Tetsuhiro Harakawa, Keiko Kato, Nakaba Sugimoto, Yoshitaka Goto, Shinji Nakahira, Tomoko Kohda, Shunji Kozaki, Ryuji Kaji, Akihiro Ginnaga

    Published 2011-01-01
    Get full text
    Article

Search Tools: